24 Feb 2026 14:30 CET

Issuer

Lifecare ASA

Lifecare ASA will release its Q4 2025 results on Tuesday, 3 March 2026 at
07:00 CET. The company will hold a webcast of the results at 10:00 CET the
same day.

The company invites you to a digital presentation of the results, followed by
a Q&A session:

Date: Tuesday, 3 March 2026
Time: 10:00 CET
Language: English
Format: Webcast via Teams

Join the webcast: Teams-meeting link
(https://teams.microsoft.com/l/meetup-join/19%3ameeting_YjUzMGE0NjQtYjNkOC00YjAz
LWE1MDUtMDgyOTZmZGQ0MDVm%40thread.v2/0?context={"Tid"%3a"10b30f00-1bbd-4041-9c4d
-64749f4a7041"%2c"Oid"%3a"3758e62c-12e5-4419-a645-4b77ef5225be"}).

A recording of the webcast will be available on the company's website after
the event. Questions can be submitted online during the session.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42


666595_Lifecare ASA (LIFE)- Invitation to Q4 2025 results presentation.pdf

Source

Lifecare ASA

Provider

Oslo Børs Newspoint

Company Name

LIFECARE ASA, LIFECARE TR ASA

ISIN

NO0013355859, NO0013709196, NO0013709204

Symbol

LIFE, LIFEJ, LIFES

Market

Euronext Oslo Børs